Rize Oncology Inc.
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -73.15% | -62.03% | -7.02% | 19.96% | 7.03% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -85.93% | -69.60% | -80.88% | -84.35% | 3,265.82% |
| Change in Net Operating Assets | 133.77% | -373.46% | -631.45% | -237.33% | -245.74% |
| Cash from Operations | -117.42% | -194.92% | -97.17% | -28.29% | 22.84% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 97.51% | 48.16% | -506.74% | -432.32% | -190.65% |
| Miscellaneous Cash Flow Adjustments | -354.44% | -- | -- | -- | -- |
| Net Change in Cash | -50.06% | -78.45% | -40.80% | 19.26% | 16.21% |